Comera Life Sciences Holdings, Inc. Stock
Equities
CMRA
US20037C1080
Biotechnology & Medical Research
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.0292 USD | -4.72% | +38.21% | -46.73% |
Jan. 30 | Comera Life Sciences Holdings, Inc. Announces Chief Executive Officer Changes | CI |
Jan. 30 | Comera Life Sciences Holdings, Inc. Announces Changes to Its Board | CI |
Financials (USD)
Sales 2021 | 320K | Sales 2022 | 633K | Capitalization | 24.41M |
---|---|---|---|---|---|
Net income 2021 | -5M | Net income 2022 | -18M | EV / Sales 2021 | 400 x |
Net cash position 2021 | 6.19M | Net Debt 2022 | 328K | EV / Sales 2022 | 39.1 x |
P/E ratio 2021 |
-7.26
x | P/E ratio 2022 |
-0.7
x | Employees | 13 |
Yield 2021 * |
-
| Yield 2022 |
-
| Free-Float | 29.53% |
1 day | -4.72% | ||
1 week | +38.21% | ||
Current month | -26.75% | ||
1 month | -28.54% | ||
3 months | -13.06% | ||
6 months | -48.42% | ||
Current year | -46.73% |
Managers | Title | Age | Since |
---|---|---|---|
Michael Campbell
CEO | Chief Executive Officer | - | 22-04-12 |
Corporate Officer/Principal | - | 22-11-08 |
Members of the board | Title | Age | Since |
---|---|---|---|
Stuart Randle
BRD | Director/Board Member | 64 | 22-05-18 |
James Sherblom
BRD | Director/Board Member | 68 | 20-12-31 |
Director/Board Member | 48 | 22-05-18 |
Date | Price | Change | Volume |
---|---|---|---|
24-05-17 | 0.0292 | -4.72% | 340 |
24-05-16 | 0.0307 | +44.81% | 2,082 |
24-05-14 | 0.0212 | 0.00% | 2,920 |
Delayed Quote OTC Markets, May 17, 2024 at 09:30 am EDT
More quotes1st Jan change | Capi. | |
---|---|---|
-46.73% | 899K | |
+44.48% | 54.04B | |
+43.57% | 41.96B | |
-0.86% | 41.92B | |
-7.59% | 28.35B | |
+12.30% | 26.35B | |
-21.83% | 19B | |
+7.15% | 13B | |
+29.40% | 12.28B | |
+25.15% | 12.19B |
- Stock Market
- Equities
- CMRA Stock